Teresa Giamboy
Primary Care · Philadelphia, PANPI 1679956122
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.5% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2024 at $11,717 and has fallen 79.8% since, to $2,367 in 2025. Among primary care clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $126.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$16K
- Pulmonx Corporation$1K
- AstraZeneca$537
- Daiichi Sankyo Inc.$372
- Novartis$289
- Gilead$221
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$11,80057%
- Travel & lodging$2,94514%
- Food & beverage$5,81728%
- Education$750%
- Gifts$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 43 | $16,446 |
| Pulmonx Corporation | 4 | $1,066 |
| AstraZeneca(2 entities) | 16 | $537 |
| Daiichi Sankyo Inc. | 20 | $372 |
| Novartis | 13 | $289 |
| Gilead | 8 | $221 |
| Inari Medical, Inc. | 1 | $209 |
| Mirati Therapeutics, Inc. | 7 | $142 |
| Boston Scientific | 1 | $136 |
| Eisai Inc. | 7 | $133 |
| Genmab U.S., Inc. | 5 | $101 |
| GSK | 1 | $100 |
| Bayer | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Galvanize Therapeutics, Inc | 2 | $94 |
| E.r. Squibb & Sons, L.L.C. | 1 | $93 |
| Astellas Pharma US Inc | 1 | $75 |
| Merck | 3 | $63 |
| Incyte Corporation | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Bristol Myers Squibb | 2 | $41 |
| Johnson & Johnson | 2 | $36 |
| Sanofi | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| Blueprint Medicines Corporation | 1 | $27 |
| Karyopharm Therapeutics Inc. | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,695 in reported general payments places this provider in the 95th percentile of 300 primary care providers in Pennsylvania.
Other primary care in Philadelphia
- Galyna VorokhibPhiladelphia$12K
- Kaylee BakerPhiladelphia$7K
- Jarrell HillPhiladelphia$6K
- Valerie DailyPhiladelphia$4K
- Adunni WardPhiladelphia$3K
- Avigad FeldmanPhiladelphia$3K
- Peggy DerussoPhiladelphia$3K
- Jennifer MalloyPhiladelphia$3K
- Emily MateyPhiladelphia$2K
- Kersten ReiderMount Penn$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.